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Skin cancer incidence rates show a tendency for continuous
increase. Along with this rise, cutaneous oncology maintains
an extensive interest for clinicians and researchers as well
as the pharmaceutical industry. This special issue highlights
and discusses exciting implications in exploration of broad
spectrum of rare and common conditions with respect to
both diagnosis and treatment of cutaneous malignancies.
An important aspect concerning angiosarcoma, a highly
aggressivemalignant tumor that still lacks a common consen-
sus for the treatment approach, has been targeted in the article
titled “Surgical Treatment and Prognosis of Angiosarcoma of
the Scalp: A Retrospective Analysis of 14 Patients in a Single
Institution” by J. H. Choi et al. Although authors report a poor
prognosis of angiosarcoma despite aggressive treatments,
they demonstrate that in case of angiosarcoma sufficiently
deep resection margins are essential for controlling local
recurrence, further highlighting the need for studies aiming
to evaluate multidisciplinary treatment modalities.
A well-structured study of a high clinical relevance
“Comparison of the Clinical Characteristics and Outcome of
Benign and Malignant Eyelid Tumors: An Analysis of 4521
Eyelid Tumors in a Tertiary Medical Center” by Y.-Y. Huang
et al. provides essential demographic and clinical features
to support differentiation between benign and malignant
eyelid tumors. Furthermore applied treatment method and
outcome in case of benign and malignant eyelid tumors are
evaluated aiming to support clinical decision to reduce the
esthetic disfigurement and morbidity especially in case of
malignant eyelid tumors.
Improving aspects of early diagnosis of skin cancer
remains a fundamental concern. The role of computer assis-
tance for clinical decision with regard to detecting skin
cancer needs to be defined and evidenced by appropriate
studies. A profoundly actual up-to-date study “Computer-
Aided Decision Support for Melanoma Detection Applied
on Melanocytic and Nonmelanocytic Skin Lesions: A Com-
parison of Two Systems Based on Automatic Analysis of
Dermoscopic Images” by K. Møllersen et al. compares capa-
bility of two clinical decision support computer systems to
detect not only melanocytic but also nonmelanocytic skin
lesions. Authors report potential of commercially available
system Nevus Doctor being able to detect nonmelanocytic
skin cancer along with remaining melanoma sensitivity
and current limitations due to misclassification of benign
nonmelanocytic lesions.
CD30+ lymphoproliferative disorder (LPD) is a rare
variant of T-cell lymphoma that in some cases is recurrent and
treatment resistant. Therefore for palliation of CD30+LPD
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to avoid unnecessary side effects of aggressive treatment
approaches radiotherapy may be considered. However there
is a lack of data endorsing radiotherapy (RT) in CD30+
LPD. M. S. Gentile et al. in the study titled “Single-Fraction
Radiotherapy forCD30+LymphoproliferativeDisorders” in a
retrospective review prominently assess the clinical response
of refractory or recurrent CD30+ lymphoproliferative disor-
der lesions to palliative radiation therapy suggesting palliative
localized RT for symptomatic CD30+ LPD refractory or
recurrent to other therapies. Study supports that palliative
radiation therapy is an effective well tolerated treatment
modality for CD30+ LPD refractory or recurrent to other
therapies and reports single fraction of 750–800 cGy being as
effective as a multifractionated course and more convenient.
In another rare malignancy, low-grade sarcoma, der-
matofibrosarcoma protuberans (DFSP) margins of the tumor
tend to extend beyond the macroscopic ones. Therefore the
incomplete removal of the tumor leads to recurrences. This
concern is accurately aimed in comprehensive clinical study
titled “Wide Local Excision for Dermatofibrosarcoma Protu-
berans: A Single-Center Series of 90 Patients” by B. J. Kim et
al. which evaluates efficacy of wide local excision for DFSP.
Authors report that wide local excision with adequate lateral
and deepmargins can effectively control local recurrence rate
and is a simple and effective method to treat DFSP.
Althoughmost skin rashes in the neonatal age are benign,
some may represent malignancy or be a feature related to
other abnormalities. Therefore to provide the best possible
outcome a considerable assessment and an adequate follow-
up for each condition are of high value. A profoundly written
educational review and a case series “The Skin as an Early
Expression of Malignancies in the Neonatal Age: A Review
of the Literature and a Case Series” by V. Mondı` et al. com-
prehensively discuss the main tumor types presenting with
a cutaneous involvement in neonates, additionally providing
a collection of didactic cases presenting with an early skin
manifestation of malignancies in illustrative case series.
A review article titled “Se´zary-Syndrome andAtopic Der-
matitis: Comparison of Immunological Aspects and Targets”
by I. Saulite et al. provides an interesting perspective by
comparing currently accepted immunological aspects and
possible therapeutic targets in atopic dermatitis (AD) and
Se´zary syndrome (SS). Authors discuss clinical appearance
and the hallmark immunological characteristics of SS high-
lighting some striking similarities with acute flares of atopic
dermatitis (AD). Taking into consideration the overlap of
several immunological features, the application of similar
therapeutic approaches in certain stages of both diseases that
may come into consideration is discussed.
Hence, with a definite commitment to improve every
aspect contributing to skin cancer this special issue consisting
of original articles and educational reviews aims to be trans-
lated in clinical advancements for patients with skin cancer.
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